4+ Y/O EU Enterprise SaaS Platform Pharma Market

Business Name: [CONFIDENTIAL NAME]
Business Start Date: 9/1/20
Business Valuation: $930,000 USD (Price lowered from $1,050,000 USD)
Business Model: Subscription-based Enterprise SaaS
Industry: Pharmaceutics, Tracking & Analytics
Percentage Being Sold: 100%
Sales (TTM): €205,700
Net Profit (TTM SDE): €200,700.00
Business Multiple (TTM ARR): 4.04x
Business Multiple (TTM EBITDA): 4.14x
Paying Clients (TTM): 20+ Enterprise Companies
Tag Line: 4+ Y/O Enterprise SaaS Platform for EU Pharma Mark
____________________________________________
Summary
This company was started in late 2020 to monitor Italian e-retails in the pharmaceutical sector. Since then it has acquired major clients such as Bayer, L'Oréal, Aboca, Haleon, and has expanded its tracking to other European countries.The company is sold turnkey as a fully automated very profitable SaaS entity that can be run successfully by 1 person.
The Opportunity
The founder is an entrepreneur. The business was born almost by chance, to learn modern programming techniques, without real business objectives. The founder had no experience or knowledge in the pharmaceutical industry, yet in a short time he created a market-leading product and managed to acquire important customers. The success of the product, which is welcome, has gone far beyond the founder's expectations.
Last year one of the customers, Aboca, surveyed all its European branches, comparing the products available in each market; This company came first in all countries. This company has thus expanded its monitoring to cover five European countries. However, it has not started commercial activities in new markets: there is therefore unexpressed potential.
The founder enjoys strong economic well-being and intends to dedicate himself to other projects. He's more than satisfied and has no incentive to further expand the business. Therefore it is reasonable to let someone more motivated exploit the company's untapped potential.
There are currently four directions for the possible growth of the business:
1) Sales in markets already under monitoring: France, Germany, Spain and Poland. This task can be immediately started.
2) Expansion in other markets, which can easily be accomplished with little effort.
3) Sales of a lower-end product, already created, to attract smaller companies.
4) Expansion into other sectors, for example the technology or the cosmetics sector, which requires some implementation efforts.
This company offers a market-validated and fully automated platform of excellent quality, which has already passed the run-in phase. Last year's revenues were over $300,000; this turnover was achieved by a single person working part-time, with a commercial partner. The technological system is ready; an adequate commercial effort can easily multiply the turnover.
General Highlights
4+ year old Italian SaaS company monitoring the online pharmaceutical pricing market at the European level.
Bootstrapped to 20 enterprise customers and growing - only requires 1 person working part time to run the business!
Revenues are over $300K with almost $240k in profit with very little expenses
All processes are fully automatized and operational needs are minimal
Technology infrastructure, well-reputed brand and leading customers are sold turn-key with the business